All Articles tagged docetaxel
Oncology
January 06, 2015 EDT Docetaxel has been a standard of care for castration-resistant prostate cancer in the United States since 2004, yet little has been reported on its patterns of use in routine practice.
Docetaxel has been a standard of care for castration-resistant prostate cancer in the United States since 2004, yet little has been reported on its patterns of use in routine practice.